The NANDA nursing diagnosis 'Risk for Infection' is crucial for understanding patient care, especially in individuals with impaired immune responses. This diagnosis is significant in patients with autoimmune disorders who are on immunosuppressive therapy, making them vulnerable to infections. Nursing students preparing for the NCLEX exam must recognize the importance of identifying and managing the risk for infection in these patients to prevent complications and promote optimal health.
Definition & Related Factors
The NANDA diagnosis 'Risk for Infection' refers to an increased risk of being invaded by pathogenic organisms. In the context of patients with autoimmune disorders undergoing immunosuppressive therapy, the body's natural defense mechanisms are compromised. Related factors include a history of recurrent infections, chronic fatigue, and the use of immunosuppressive medications that suppress immune function. Understanding these factors is essential for nursing students to develop a comprehensive care plan aimed at minimizing infection risks.
Assessment Findings
Nurses should assess both subjective and objective data to identify the risk of infection. Subjective findings may include the patient's report of chronic fatigue, history of recurrent infections, and the use of medications that compromise immune function. Objective findings include laboratory results indicating low white blood cell counts or other signs of immunosuppression. Additionally, nurses should observe for any signs of infection such as fever, redness, or swelling.
Expected Outcomes & Goals
The primary goal is to prevent infection in patients at risk. Expected outcomes include the patient remaining free from signs and symptoms of infection, understanding and demonstrating infection prevention measures, and maintaining stable vital signs. These outcomes should be measurable and time-bound to ensure effective evaluation of the care plan.
Key Nursing Interventions
Nursing interventions include monitoring vital signs and laboratory values closely for early signs of infection, educating patients on proper hand hygiene and infection prevention strategies, and ensuring timely administration of prophylactic medications as ordered. Providing a clean environment and limiting exposure to potential sources of infection are vital. Rationales for these interventions are based on reducing exposure to pathogens and enhancing the patient's understanding and compliance with infection prevention.
NCLEX Tips
Risk for Infection often appears on the NCLEX in scenarios involving patients with compromised immune systems, such as those on immunosuppressive therapy. Key points include recognizing signs of infection, understanding immunosuppressive medication effects, and implementing infection control practices. Questions may focus on prioritizing nursing interventions to prevent infections and evaluating the effectiveness of care plans.
Practice NCLEX Question
A patient with a history of autoimmune disorder is on immunosuppressive therapy. What is the priority nursing diagnosis?
A. Risk for Infection
B. Acute Pain
C. Impaired Skin Integrity
D. Activity Intolerance
Show Answer & Rationale
Correct Answer: A
Patients on immunosuppressive therapy are at increased risk for infection due to compromised immune responses, making this the priority diagnosis.
Frequently Asked Questions
What is Risk for Infection in nursing?
Risk for Infection is a nursing diagnosis indicating an increased risk of invasion by pathogenic organisms due to compromised immune defenses.
What are the priority nursing interventions for Risk for Infection?
Priority interventions include monitoring for infection signs, educating on hygiene practices, and ensuring a clean environment.
How does Risk for Infection appear on the NCLEX?
It appears in questions about patients with compromised immune systems, focusing on infection prevention and early detection.
What assessment findings indicate Risk for Infection?
Assessment findings include chronic fatigue, recurrent infections, and low white blood cell counts in patients on immunosuppressive therapy.